Login to Your Account

Drug and device reform lead Australia's TGA priorities for year ahead

By Tamra Sami
Staff Writer

Wednesday, November 29, 2017

PERTH, Australia – Implementing drug and device regulatory reforms that were begun in 2017 will continue to be top priorities for Australia's Therapeutic Goods Administration, according to its newly published TGA Business Plan 2017-18.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription